A citation-based method for searching scientific literature

Triin Eller, Veiko Vasar, Jakov Shlik, Eduard Maron. Prog Neuropsychopharmacol Biol Psychiatry 2008
Times Cited: 209







List of co-cited articles
1177 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
62

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
883
42

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
552
39

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
509
38

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
35

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
35

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
301
32

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.
Sinead M O'Brien, Paul Scully, Peter Fitzgerald, Lucinda V Scott, Timothy G Dinan. J Psychiatr Res 2007
263
29

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
27

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
472
26

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
210
26

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Nobuhisa Ueda, Jun Nakamura. Prog Neuropsychopharmacol Biol Psychiatry 2009
133
25


Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
272
22

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
457
21

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
17

Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy.
Levent Sutcigil, Cagatay Oktenli, Ugur Musabak, Ali Bozkurt, Adnan Cansever, Ozcan Uzun, S Yavuz Sanisoglu, Zeki Yesilova, Nahit Ozmenler, Aytekin Ozsahin,[...]. Clin Dev Immunol 2007
221
17

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
488
16

Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
Jian-Jun Yang, Nan Wang, Chun Yang, Jin-Yun Shi, Hai-Ying Yu, Kenji Hashimoto. Biol Psychiatry 2015
103
16

A detailed examination of cytokine abnormalities in Major Depressive Disorder.
N M Simon, K McNamara, C W Chow, R S Maser, G I Papakostas, M H Pollack, A A Nierenberg, M Fava, K K Wong. Eur Neuropsychopharmacol 2008
199
16

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.
Cengiz Tuglu, S Hakan Kara, Okan Caliyurt, Erdal Vardar, Ercan Abay. Psychopharmacology (Berl) 2003
269
16

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
461
16

IL-6 levels decrease with SSRI treatment in patients with major depression.
Ayse Devrim Basterzi, Cigdem Aydemir, Cebrail Kisa, Sabahat Aksaray, Verda Tuzer, Kemal Yazici, Erol Göka. Hum Psychopharmacol 2005
158
15

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
15


Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
693
15

Treatment response and cognitive impairment in major depression: association with C-reactive protein.
Hui Hua Chang, I Hui Lee, Po Wu Gean, Sheng-Yu Lee, Mei Hung Chi, Yen Kuang Yang, Ru-Band Lu, Po See Chen. Brain Behav Immun 2012
66
22

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
516
15

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Asuka Katsuki, Kiyokazu Atake, Jun Nakamura. Hum Psychopharmacol 2013
45
31

The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.
Chong-Bin Zhu, Randy D Blakely, William A Hewlett. Neuropsychopharmacology 2006
341
13

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.
O Mikova, R Yakimova, E Bosmans, G Kenis, M Maes. Eur Neuropsychopharmacol 2001
213
13

Pro-inflammatory biomakers in depression: treatment with venlafaxine.
John E Piletz, Angelos Halaris, Omer Iqbal, Debra Hoppensteadt, Jawed Fareed, He Zhu, James Sinacore, C Lindsay Devane. World J Biol Psychiatry 2009
96
13

Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine.
Aarthi Manoharan, Ravi Philip Rajkumar, Deepak Gopal Shewade, Rajan Sundaram, Avin Muthuramalingam, Abialbon Paul. Hum Psychopharmacol 2016
22
59

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
13

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
191
12


Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.
María Eugenia Hernández, Danelia Mendieta, Daniel Martínez-Fong, Frida Loría, Julia Moreno, Iris Estrada, Rafael Bojalil, Lenin Pavón. Eur Neuropsychopharmacol 2008
100
12

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
611
12

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.
Timothy R Powell, Leonard C Schalkwyk, Andrew L Heffernan, Gerome Breen, Timothy Lawrence, Tom Price, Anne E Farmer, Katherine J Aitchison, Ian W Craig, Andrea Danese,[...]. Eur Neuropsychopharmacol 2013
55
21


Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.
Jennifer L Kruse, Eliza Congdon, Richard Olmstead, Stephanie Njau, Elizabeth C Breen, Katherine L Narr, Randall Espinoza, Michael R Irwin. J Clin Psychiatry 2018
33
36

Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Ebrahim Haroon, Alexander W Daguanno, Bobbi J Woolwine, David R Goldsmith, Wendy M Baer, Evanthia C Wommack, Jennifer C Felger, Andrew H Miller. Psychoneuroendocrinology 2018
93
12

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
Jennifer L Warner-Schmidt, Kimberly E Vanover, Emily Y Chen, John J Marshall, Paul Greengard. Proc Natl Acad Sci U S A 2011
197
11

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Stephen Tyring, Alice Gottlieb, Kim Papp, Ken Gordon, Craig Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik,[...]. Lancet 2006
737
11

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner, Martin Walter, Tomasz Gos, Gilles J Guillemin, Hans-Gert Bernstein, Zoltán Sarnyai, Christian Mawrin, Ralf Brisch, Hendrik Bielau, Louise Meyer zu Schwabedissen,[...]. J Neuroinflammation 2011
339
11

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
Johan Dahl, Heidi Ormstad, Hans Christian D Aass, Ulrik Fredrik Malt, Lil Träskman Bendz, Leiv Sandvik, Lena Brundin, Ole A Andreassen. Psychoneuroendocrinology 2014
200
10


A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.
Ross J Tynan, Judith Weidenhofer, Madeleine Hinwood, Murray J Cairns, Trevor A Day, Frederick R Walker. Brain Behav Immun 2012
208
10

Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression.
Mona Moieni, Michael R Irwin, Ivana Jevtic, Richard Olmstead, Elizabeth C Breen, Naomi I Eisenberger. Neuropsychopharmacology 2015
147
10

Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.
Naomi I Eisenberger, Elliot T Berkman, Tristen K Inagaki, Lian T Rameson, Nehjla M Mashal, Michael R Irwin. Biol Psychiatry 2010
325
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.